Adult Malignant Glioma Treatment - Global and China Top Players Market Share and Ranking 2024
- Report Code : AMP2755937
- Published On: Jul, 2024
- Category : Healthcare & Pharma
- Pages : 145
-
According to Ample Market Research, the global market for Adult Malignant Glioma Treatment should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Adult Malignant Glioma Treatment market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030. The United States Adult Malignant Glioma Treatment market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
By segment, Glioblastoma Multiforme grew percent to account for percent of the total market sales, and Anaplastic Astrocytoma grew percent.
Malignant gliomas, tumors derived from the neuroepithelium are collectively referred to as gliomas (gliomas), accounting for 40-50% of brain tumors, and are the most common intracranial malignant tumors. According to pathology, it can be divided into astrocytoma, medulloblastoma, glioblastoma multiforme, ependymoma, oligodendroglioma and so on.
This report studies and analyses global Adult Malignant Glioma Treatment status and future trends, helps the client to determine the Adult Malignant Glioma Treatment market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Adult Malignant Glioma Treatment, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2024 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Adult Malignant Glioma Treatment market size, history data 2019-2024, and forecast data 2024 -2030, (US$ million) & (K Units)
(2) Global Adult Malignant Glioma Treatment sales, revenue, price by company, market share and industry ranking 2019-2024, (US$ million) & (K Units)
(3) China Adult Malignant Glioma Treatment sales, revenue, price by company, market share and industry ranking 2019-2024, (US$ million) & (K Units)
(4) Global Adult Malignant Glioma Treatment key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Adult Malignant Glioma Treatment key producing regions, capacity, production, and year over year growth
(6) Adult Malignant Glioma Treatment industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Merck & Co., Inc
F. Hoffmann-La Roche Ltd
Arbor Pharmaceuticals
Pfizer,Inc
AbbVie, Inc
Amgen, Inc
Bristol-Myers Squibb Company
Sun Pharmaceuticals Ltd
Teva Pharmaceutical Industries Limited
Emcure Pharmaceuticals Limited
Bayer
SL Pharm
Boan Biotech
Market segment by Type, covers
Chemotherapy
Targeted Drug Therapy
Market segment by Application, can be divided into
Glioblastoma Multiforme
Anaplastic Astrocytoma
Anaplastic Oligodendroglioma
Anaplastic Oligoastrocytoma
Other
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Adult Malignant Glioma Treatment product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Adult Malignant Glioma Treatment market share and ranking of major manufacturers, sales quantity, revenue, average price, 2019-2024
Chapter 3: China Adult Malignant Glioma Treatment market share and ranking of major manufacturers, sales quantity, revenue, average price, 2019-2024
Chapter 4: Global key producing regions of Adult Malignant Glioma Treatment, percent & CAGR, 2019-2030
Chapter 5: Adult Malignant Glioma Treatment industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2019-2030
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2019-2030
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2019-2030
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2019-2030
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
-
With tables and figures helping analyze worldwide Adult Malignant Glioma Treatment Global and China Top Players market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Market Overview1.1 Adult Malignant Glioma Treatment Definition
1.2 Global Adult Malignant Glioma Treatment Market Size and Forecast
1.2.1 By Consumption Value, Global Adult Malignant Glioma Treatment Market Size，2019-2030
1.2.2 By Sales Quantity, Global Adult Malignant Glioma Treatment Market Size，2019-2030
1.2.3 Global Adult Malignant Glioma Treatment Average Selling Price (ASP)，2019-20301.3 China Adult Malignant Glioma Treatment Market Size and Forecast
1.3.1 By Consumption Value, China Adult Malignant Glioma Treatment Market Size，2019-2030
1.3.2 By Sales Quantity, China Adult Malignant Glioma Treatment Market Size，2019-2030
1.3.3 China Adult Malignant Glioma Treatment Average Selling Price (ASP)， 2019-20301.4 Share of China Adult Malignant Glioma Treatment Market with Respect to the Global Market
1.4.1 By Consumption Value, China Adult Malignant Glioma Treatment Market Share in Global, 2019-2030
1.4.2 By Sales Quantity, China Adult Malignant Glioma Treatment Market Share in Global, 2019-2030
1.4.3 Adult Malignant Glioma Treatment Market Size: China VS Global, 2019-20301.5 Adult Malignant Glioma Treatment Market Dynamics
1.5.1 Adult Malignant Glioma Treatment Market Drivers
1.5.2 Adult Malignant Glioma Treatment Market Restraints
1.5.3 Adult Malignant Glioma Treatment Industry Trends
1.5.4 Adult Malignant Glioma Treatment Industry Policy
2 Global Leading Manufacturers and Market Share2.1 By Revenue of Adult Malignant Glioma Treatment, Global Market Share by Company, 2019-2024
2.2 By Sales Quantity of Adult Malignant Glioma Treatment, Global Market Share by Company, 2019-2024
2.3 Adult Malignant Glioma Treatment Average Selling Price (ASP) by Company, 2019-2024
2.4 Global Adult Malignant Glioma Treatment Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Adult Malignant Glioma Treatment Concentration Ratio
2.6 Global Adult Malignant Glioma Treatment Mergers & Acquisitions, Expansion Plans
2.7 Global Adult Malignant Glioma Treatment Manufacturers Product Type
2.8 Head Office and Adult Malignant Glioma Treatment Production Site of Key Manufacturer
2.9 Adult Malignant Glioma Treatment Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share3.1 By Revenue of Adult Malignant Glioma Treatment, China Market Share by Company, 2019-2024
3.2 By Sales Quantity of Adult Malignant Glioma Treatment, China Market Share by Company, 2019-2024
3.3 China Adult Malignant Glioma Treatment Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions4.1 Global Adult Malignant Glioma Treatment Capacity, Output and Capacity Utilization, 2019-2030
4.2 Global Adult Malignant Glioma Treatment Capacity by Region
4.3 Global Adult Malignant Glioma Treatment Production & Forecast by Region, 2019 VS 2024 VS 2030
4.4 Global Adult Malignant Glioma Treatment Production by Region, 2019-2030
4.5 Global Adult Malignant Glioma Treatment Production Market Share & Forecast by Region, 2019-2030
5 Industry Chain Analysis5.1 Adult Malignant Glioma Treatment Industry Chain
5.2 Adult Malignant Glioma Treatment Upstream Analysis
5.2.1 Adult Malignant Glioma Treatment Core Raw Materials
5.2.2 Main Manufacturers of Adult Malignant Glioma Treatment Core Raw Materials5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Adult Malignant Glioma Treatment Production Mode
5.6 Adult Malignant Glioma Treatment Procurement Model
5.7 Adult Malignant Glioma Treatment Industry Sales Model and Sales Channels
5.7.1 Adult Malignant Glioma Treatment Sales Model
5.7.2 Adult Malignant Glioma Treatment Typical Distributors
6 Sights by Type6.1 Adult Malignant Glioma Treatment Classification
6.1.1 Chemotherapy
6.1.2 Targeted Drug Therapy6.2 By Type, Global Adult Malignant Glioma Treatment Consumption Value & CAGR, 2019 VS 2024 VS 2030
6.3 By Type, Global Adult Malignant Glioma Treatment Consumption Value, 2019-2030
6.4 By Type, Global Adult Malignant Glioma Treatment Sales Quantity, 2019-2030
6.5 By Type, Global Adult Malignant Glioma Treatment Average Selling Price (ASP), 2019-2030
7 Sights by Application7.1 Adult Malignant Glioma Treatment Segment by Application
7.1.1 Glioblastoma Multiforme
7.1.2 Anaplastic Astrocytoma
7.1.3 Anaplastic Oligodendroglioma
7.1.4 Anaplastic Oligoastrocytoma
7.1.5 Other7.2 By Application, Global Adult Malignant Glioma Treatment Consumption Value & CAGR, 2019 VS 2024 VS 2030
7.3 By Application, Global Adult Malignant Glioma Treatment Consumption Value, 2019-2030
7.4 By Application, Global Adult Malignant Glioma Treatment Sales Quantity, 2019-2030
7.5 By Application, Global Adult Malignant Glioma Treatment Price, 2019-2030
8 Sales Sights by Region8.1 By Region, Global Adult Malignant Glioma Treatment Consumption Value, 2019 VS 2024 VS 2030
8.2 By Region, Global Adult Malignant Glioma Treatment Consumption Value, 2019-2030
8.3 By Region, Global Adult Malignant Glioma Treatment Sales Quantity, 2019-2030
8.4 North America
8.4.1 North America Adult Malignant Glioma Treatment & Forecasts, 2019-2030
8.4.2 By Country, North America Adult Malignant Glioma Treatment Market Size Market Share8.5 Europe
8.5.1 Europe Adult Malignant Glioma Treatment Market Size & Forecasts, 2019-2030
8.5.2 By Country, Europe Adult Malignant Glioma Treatment Market Size Market Share8.6 Asia Pacific
8.6.1 Asia Pacific Adult Malignant Glioma Treatment Market Size & Forecasts, 2019-2030
8.6.2 By Country/Region, Asia Pacific Adult Malignant Glioma Treatment Market Size Market Share
8.7 South America
8.7.1 South America Adult Malignant Glioma Treatment Market Size & Forecasts, 2019-2030
8.7.2 By Country, South America Adult Malignant Glioma Treatment Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level9.1 By Country, Global Adult Malignant Glioma Treatment Market Size & CAGR, 2019 VS 2024 VS 2030
9.2 By Country, Global Adult Malignant Glioma Treatment Consumption Value, 2019-2030
9.3 By Country, Global Adult Malignant Glioma Treatment Sales Quantity, 2019-2030
9.4 U.S.
9.4.1 U.S. Adult Malignant Glioma Treatment Market Size, 2019-2030
9.4.2 By Type, U.S. Adult Malignant Glioma Treatment Sales Quantity Market Share, 2024 VS 2030
9.4.3 By Application, U.S. Adult Malignant Glioma Treatment Sales Quantity Market Share, 2024 VS 20309.5 Europe
9.5.1 Europe Adult Malignant Glioma Treatment Market Size, 2019-2030
9.5.2 By Type, Europe Adult Malignant Glioma Treatment Sales Quantity Market Share, 2024 VS 2030
9.5.3 By Application, Europe Adult Malignant Glioma Treatment Sales Quantity Market Share, 2024 VS 20309.6 China
9.6.1 China Adult Malignant Glioma Treatment Market Size, 2019-2030
9.6.2 By Type, China Adult Malignant Glioma Treatment Sales Quantity Market Share, 2024 VS 2030
9.6.3 By Application, China Adult Malignant Glioma Treatment Sales Quantity Market Share, 2024 VS 2030
9.7 Japan
9.7.1 Japan Adult Malignant Glioma Treatment Market Size, 2019-2030
9.7.2 By Type, Japan Adult Malignant Glioma Treatment Sales Quantity Market Share, 2024 VS 2030
9.7.3 By Application, Japan Adult Malignant Glioma Treatment Sales Quantity Market Share, 2024 VS 2030
9.8 South Korea
9.8.1 South Korea Adult Malignant Glioma Treatment Market Size, 2019-2030
9.8.2 By Type, South Korea Adult Malignant Glioma Treatment Sales Quantity Market Share, 2024 VS 2030
9.8.3 By Application, South Korea Adult Malignant Glioma Treatment Sales Quantity Market Share, 2024 VS 2030
9.9 Southeast Asia
9.9.1 Southeast Asia Adult Malignant Glioma Treatment Market Size, 2019-2030
9.9.2 By Type, Southeast Asia Adult Malignant Glioma Treatment Sales Quantity Market Share, 2024 VS 2030
9.9.3 By Application, Southeast Asia Adult Malignant Glioma Treatment Sales Quantity Market Share, 2024 VS 20309.10 India
9.10.1 India Adult Malignant Glioma Treatment Market Size, 2019-2030
9.10.2 By Type, India Adult Malignant Glioma Treatment Sales Quantity Market Share, 2024 VS 2030
9.10.3 By Application, India Adult Malignant Glioma Treatment Sales Quantity Market Share, 2024 VS 2030
9.11 Middle East & Africa
9.11.1 Middle East & Africa Adult Malignant Glioma Treatment Market Size, 2019-2030
9.11.2 By Type, Middle East & Africa Adult Malignant Glioma Treatment Sales Quantity Market Share, 2024 VS 2030
9.11.3 By Application, Middle East & Africa Adult Malignant Glioma Treatment Sales Quantity Market Share, 2024 VS 2030
10 Manufacturers Profile10.1 Merck & Co., Inc
10.1.1 Merck & Co., Inc Company Information, Head Office, Market Area, and Industry Position
10.1.2 Merck & Co., Inc Adult Malignant Glioma Treatment Models, Specifications, and Application
10.1.3 Merck & Co., Inc Adult Malignant Glioma Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.1.4 Merck & Co., Inc Company Profile and Main Business
10.1.5 Merck & Co., Inc Recent Developments10.2 F. Hoffmann-La Roche Ltd
10.2.1 F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area, and Industry Position
10.2.2 F. Hoffmann-La Roche Ltd Adult Malignant Glioma Treatment Models, Specifications, and Application
10.2.3 F. Hoffmann-La Roche Ltd Adult Malignant Glioma Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.2.4 F. Hoffmann-La Roche Ltd Company Profile and Main Business
10.2.5 F. Hoffmann-La Roche Ltd Recent Developments10.3 Arbor Pharmaceuticals
10.3.1 Arbor Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.3.2 Arbor Pharmaceuticals Adult Malignant Glioma Treatment Models, Specifications, and Application
10.3.3 Arbor Pharmaceuticals Adult Malignant Glioma Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.3.4 Arbor Pharmaceuticals Company Profile and Main Business
10.3.5 Arbor Pharmaceuticals Recent Developments10.4 Pfizer,Inc
10.4.1 Pfizer,Inc Company Information, Head Office, Market Area, and Industry Position
10.4.2 Pfizer,Inc Adult Malignant Glioma Treatment Models, Specifications, and Application
10.4.3 Pfizer,Inc Adult Malignant Glioma Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.4.4 Pfizer,Inc Company Profile and Main Business
10.4.5 Pfizer,Inc Recent Developments10.5 AbbVie, Inc
10.5.1 AbbVie, Inc Company Information, Head Office, Market Area, and Industry Position
10.5.2 AbbVie, Inc Adult Malignant Glioma Treatment Models, Specifications, and Application
10.5.3 AbbVie, Inc Adult Malignant Glioma Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.5.4 AbbVie, Inc Company Profile and Main Business
10.5.5 AbbVie, Inc Recent Developments10.6 Amgen, Inc
10.6.1 Amgen, Inc Company Information, Head Office, Market Area, and Industry Position
10.6.2 Amgen, Inc Adult Malignant Glioma Treatment Models, Specifications, and Application
10.6.3 Amgen, Inc Adult Malignant Glioma Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.6.4 Amgen, Inc Company Profile and Main Business
10.6.5 Amgen, Inc Recent Developments
10.7 Bristol-Myers Squibb Company
10.7.1 Bristol-Myers Squibb Company Company Information, Head Office, Market Area, and Industry Position
10.7.2 Bristol-Myers Squibb Company Adult Malignant Glioma Treatment Models, Specifications, and Application
10.7.3 Bristol-Myers Squibb Company Adult Malignant Glioma Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.7.4 Bristol-Myers Squibb Company Company Profile and Main Business
10.7.5 Bristol-Myers Squibb Company Recent Developments
10.8 Sun Pharmaceuticals Ltd
10.8.1 Sun Pharmaceuticals Ltd Company Information, Head Office, Market Area, and Industry Position
10.8.2 Sun Pharmaceuticals Ltd Adult Malignant Glioma Treatment Models, Specifications, and Application
10.8.3 Sun Pharmaceuticals Ltd Adult Malignant Glioma Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.8.4 Sun Pharmaceuticals Ltd Company Profile and Main Business
10.8.5 Sun Pharmaceuticals Ltd Recent Developments
10.9 Teva Pharmaceutical Industries Limited
10.9.1 Teva Pharmaceutical Industries Limited Company Information, Head Office, Market Area, and Industry Position
10.9.2 Teva Pharmaceutical Industries Limited Adult Malignant Glioma Treatment Models, Specifications, and Application
10.9.3 Teva Pharmaceutical Industries Limited Adult Malignant Glioma Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.9.4 Teva Pharmaceutical Industries Limited Company Profile and Main Business
10.9.5 Teva Pharmaceutical Industries Limited Recent Developments10.10 Emcure Pharmaceuticals Limited
10.10.1 Emcure Pharmaceuticals Limited Company Information, Head Office, Market Area, and Industry Position
10.10.2 Emcure Pharmaceuticals Limited Adult Malignant Glioma Treatment Models, Specifications, and Application
10.10.3 Emcure Pharmaceuticals Limited Adult Malignant Glioma Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.10.4 Emcure Pharmaceuticals Limited Company Profile and Main Business
10.10.5 Emcure Pharmaceuticals Limited Recent Developments
10.11 Bayer
10.11.1 Bayer Company Information, Head Office, Market Area, and Industry Position
10.11.2 Bayer Adult Malignant Glioma Treatment Models, Specifications, and Application
10.11.3 Bayer Adult Malignant Glioma Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.11.4 Bayer Company Profile and Main Business
10.11.5 Bayer Recent Developments
10.12 SL Pharm
10.12.1 SL Pharm Company Information, Head Office, Market Area, and Industry Position
10.12.2 SL Pharm Adult Malignant Glioma Treatment Models, Specifications, and Application
10.12.3 SL Pharm Adult Malignant Glioma Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.12.4 SL Pharm Company Profile and Main Business
10.12.5 SL Pharm Recent Developments
10.13 Boan Biotech
10.13.1 Boan Biotech Company Information, Head Office, Market Area, and Industry Position
10.13.2 Boan Biotech Adult Malignant Glioma Treatment Models, Specifications, and Application
10.13.3 Boan Biotech Adult Malignant Glioma Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.13.4 Boan Biotech Company Profile and Main Business
10.13.5 Boan Biotech Recent Developments
11 Conclusion
12 Appendix12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources12.3 Market Estimation Model
12.4 Disclaimer
-
The Adult Malignant Glioma Treatment Global and China Top Players Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Recognize the areas along the Adult Malignant Glioma Treatment Global and China Top Players Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
The Adult Malignant Glioma Treatment Global and China Top Players Market is expected to reach a reasonable valuation by 2029; now the market is expected to shift its focus from growth to value.
As the shift to value addition continues, companies in the Adult Malignant Glioma Treatment Global and China Top Players Market face the dual challenge of improving interoperability to optimize performance and experience.
The Adult Malignant Glioma Treatment Global and China Top Players Market is expected to reach a considerable market valuation.
